From: The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe
Number of patients (%) | ||
---|---|---|
Reasons | "Before" subgroup (n = 1,039)* | "After" subgroup (n = 393)** |
Lack of efficacy of previous treatment | 498 (49.0%) | 222 (57.2%) |
Adverse event under previous treatment | 259 (25.5%) | 73 (18.8%) |
Patient desire to continue | 146 (14.4%) | 41 (10.6%) |
Non compliance to previous treatment | 74 (7.2%) | 27 (7.0%) |
Other reasons | 40 (3.9%) | 25 (6.4%) |
Total | 1,017 (100.0%) | 388 (100.0%) |